Nyxoah Reports Second Quarter and First Half 2024 Financial and Operating Results
FDA regulatory submission complete, U.S. approval on track for end of 2024
U.S. commercial laun......
Record quarterly GAAP and Non-GAAP operating margins
Raises 2024 revenue and Non-GAAP operating margin guidance
Continuing to invest in the fast-growing Unified SASE and Security Operations markets
All 157 Partners to Remain Long-Term Owners | Brand, Independence & Legacy Maintained | Firm Poised for Continued Growth in the United Kingdom and Beyond
